All Stories

  1. Celecoxib and Dimethylcelecoxib Block Oxidative Phosphorylation, Epithelial-Mesenchymal Transition and Invasiveness in Breast Cancer Stem Cells
  2. Drug Target Selection for Trypanosoma cruzi Metabolism by Metabolic Control Analysis and Kinetic Modeling
  3. Mutant p53R248Q downregulates oxidative phosphorylation and upregulates glycolysis under normoxia and hypoxia in human cervix cancer cells
  4. Understanding the cancer cell phenotype beyond the limitations of current omics analyses
  5. Cancer energy metabolism under hypoglycemia
  6. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms
  7. GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids
  8. Canonical and new generation anticancer drugs also target energy metabolism
  9. Who controls the ATP supply in cancer cells? Biochemistry lessons to understand cancer energy metabolism
  10. Zn-bis-glutathionate is the best co-substrate of the monomeric phytochelatin synthase from the photosynthetic heavy metal-hyperaccumulator Euglena gracilis
  11. The 2-oxoglutarate supply exerts significant control on the lysine synthesis flux inSaccharomyces cerevisiae
  12. Systems Biology Approaches to Cancer Energy Metabolism
  13. Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids
  14. Reactive oxygen species are generated by the respiratory complex II – evidence for lack of contribution of the reverse electron flow in complex I
  15. Metabolic Control Analysis, Drug-Target Identification
  16. Metabolic Control Theory
  17. Elasticity Coefficient
  18. Summation Theorem
  19. Rate-limiting Step
  20. Regulation Analysis
  21. Response Coefficient
  22. Flux Control Coefficient
  23. Concentration Control Coefficient
  24. Connectivity Theorem
  25. The bifunctional aldehyde–alcohol dehydrogenase controls ethanol and acetate production in Entamoeba histolytica under aerobic conditions
  26. Sulfate uptake in photosynthetic Euglena gracilis. Mechanisms of regulation and contribution to cysteine homeostasis
  27. Molecular mechanism for the selective impairment of cancer mitochondrial function by a mitochondrially targeted vitamin E analogue
  28. Drug target validation of the trypanothione pathway enzymes through metabolic modelling
  29. Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation
  30. The Lys20 homocitrate synthase isoform exerts most of the flux control over the lysine synthesis pathway in Saccharomyces cerevisiae
  31. Multi-biomarker pattern for tumor identification and prognosis
  32. Inhibitors of Succinate: Quinone Reductase/Complex II Regulate Production of Mitochondrial Reactive Oxygen Species and Protect Normal Cells from Ischemic Damage but Induce Specific Cancer Cell Death
  33. Oxidative Phosphorylation as a Target to Arrest Malignant Neoplasias
  34. Modeling cancer glycolysis
  35. Phosphofructokinase type 1 kinetics, isoform expression and gene polymorphisms in cancer cells
  36. Targeting Trypanothione Metabolism in Trypanosomatid Human Parasites
  37. Metabolic control analysis indicates a change of strategy in the treatment of cancer
  38. Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma
  39. Pyruvate:ferredoxin oxidoreductase and bifunctional aldehyde–alcohol dehydrogenase are essential for energy metabolism under oxidative stress in Entamoeba histolytica
  40. The causes of cancer revisited: “Mitochondrial malignancy” and ROS-induced oncogenic transformation – Why mitochondria are targets for cancer therapy
  41. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger
  42. Kinetics of transport and phosphorylation of glucose in cancer cells
  43. HIF-1α Modulates Energy Metabolism in Cancer Cells by Inducing Over-Expression of Specific Glycolytic Isoforms
  44. Molecular basis of the unusual catalytic preference for GDP/GTP in Entamoeba histolytica 3‐phosphoglycerate kinase
  45. The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?
  46. Targeting of cancer energy metabolism
  47. Glycolysis inUstilago maydis
  48. Gene Cloning and Biochemical Characterization of an Alcohol Dehydrogenase from Euglena gracilis1
  49. Experimental validation of metabolic pathway modeling
  50. Metabolic Control Analysis: A Tool for Designing Strategies to Manipulate Metabolic Pathways
  51. Enhanced alternative oxidase and antioxidant enzymes under Cd2+ stress in Euglena
  52. Kinetic modeling can describe in vivo glycolysis in Entamoeba histolytica
  53. Energy metabolism in tumor cells
  54. Phytochelatin–cadmium–sulfide high‐molecular‐mass complexes of Euglena gracilis
  55. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells
  56. Determining and understanding the control of glycolysis in fast‐growth tumor cells
  57. Physiological role of rhodoquinone in Euglena gracilis mitochondria
  58. The bacterial-like lactate shuttle components from heterotrophic Euglena gracilis
  59. Structural and functional changes in heart mitochondria from sucrose-fed hypertriglyceridemic rats
  60. Glycolysis in Entamoeba histolytica
  61. The Alternative Respiratory Pathway of Euglena Mitochondria
  62. Control of superoxide production in mitochondria from maize mesocotyls
  63. Entamoeba histolytica: kinetic and molecular evidence of a previously unidentified pyruvate kinase
  64. Cytosol–mitochondria transfer of reducing equivalents by a lactate shuttle in heterotrophic Euglena
  65. The Membrane-Bound - and -Lactate Dehydrogenase Activities in Mitochondria from Euglena gracilis
  66. Multisite control of the Crabtree effect in ascites hepatoma cells
  67. Oxidative phosphorylation supported by an alternative respiratory pathway in mitochondria from Euglena
  68. Substrate Oxidation and ATP Supply in AS-30D Hepatoma Cells
  69. A Method for the Isolation of Tegument Syncytium Mitochondria from Taenia crassiceps Cysticerci and Partial Characterization of Their Aerobic Metabolism
  70. The Content of Alternative Oxidase of Euglena Mitochondria is Increased by Growth in the Presence of Cyanide and is not Cytochrome o.
  71. Potassium Collapses the ΔPin Yeast Mitochondria While the Rate of ATP Synthesis Is Inhibited Only Partially: Modulation by Phosphate
  72. Effect of intramitochondrial Mg2 on citrulline synthesis in rat liver mitochondria
  73. On the mechanism by which 6-ketocholestanol protects mitochondria against uncoupling-induced Ca2+efflux
  74. Modulation of matrix Ca2+ content by the ADP/ATP carrier in brown adipose tissue mitochondria. Influence of membrane lipid composition
  75. Modulation of matrix Ca2+ content by the ADP/ATP carrier in brown adipose tissue mitochondria. Influence of membrane lipid composition
  76. Modulation of 2-Oxoglutarate Dehydrogenase and Oxidative Phosphorylation by Ca2+ in Pancreas and Adrenal Cortex Mitochondria
  77. Characterization of Ca2+ transport in Euglena gracilis mitochondria
  78. The proton pumping activity of H+-ATPases: An improved fluorescence assay
  79. Control of oxidative phosphorylation in AS-30D hepatoma mitochondria
  80. Energy-dependent reactions supported by several substrates in coupled Euglena gracilis mitochondria
  81. Distribution of control of oxidative phosphorylation in mitochondria oxidizing NAD-linked substrates
  82. Inhibition of substrate oxidation in mitochondria by the peripheral-type benzodiazepine receptor ligand AHN 086
  83. Control of oxidative phosphorylation in mitochondria, cells and tissues
  84. Release of Ca2+ from heart and kidney mitochondria by peripheral-type benodiazepine receptor ligands
  85. Activation of Pyruvate Dehydrogenase Complex by Ca2+in Intact Heart, Cardiac Myocytes, and Cardiac Mitochondria
  86. Control of Respiration and ATP Hydrolysis in Uncoupled Mitochondria
  87. Preparation of coupled mitochondria from Euglena by sonication